On January 11, Chongqing Fuan Pharmaceutical (Group) Co.Ltd(300194) (300194) announced that Hubei people’s Pharmaceutical Co., Ltd. (people’s pharmaceutical) of the company’s subsidiary Fuan Pharmaceutical (Group) Co.Ltd(300194) group recently received the notice of approval for drug supplementary application approved and issued by the State Food and drug administration, and its product “omeprazole sodium for injection (specification: 40mg, registration classification: chemical)” passed the consistency evaluation of quality and efficacy of generic drugs.
Omeprazole sodium for injection is mainly used as an alternative therapy for the following diseases when oral therapy is not applicable: duodenal ulcer, gastric ulcer, reflux esophagitis, etc. At present, many manufacturers in China have obtained production approval.
